All Asset allocation articles – Page 9
-
White papers
The Opportunity Cost of Waiting for Goldilocks
Waiting for a “Goldilocks moment” to add duration back into your portfolio can be costly and difficult to execute. Find out why allocating across duration exposures, or “riding the curve,” may offer a better approach.
-
White papers
Private vs. Public Investment Strategies – Reported and Real-World Performance
Based on reported cumulative returns, private assets – especially buyout funds – outperformed public assets by a wide margin from 2005 to 2021. However, this traditional performance comparison is misleading because reported performance of private assets does not reflect the real-world performance experienced by CIOs.
-
White papers
Why are fallen angels the pick of high yield?
How could fallen angels offer a high-yield (HY) exposure of superior quality in a strategic allocation? We consider how investors can use these bonds to improve performance potential while mitigating relative ratings risk. In our previous insight of this three-part series, we made the case for a dedicated allocation to the segment due to the ability of price recovery to drive outperformance, and a compelling supply outlook.
-
White papers
Asset Allocation Committee Outlook: 2Q 2023
Despite equities holding up well so far in 2023, the Asset Allocation Committee remains cautious, anticipating volatility as we approach peaks in rates and inflation and troughs in economic growth and earnings.
-
White papers
Private debt market outlook: The opportunity of a lifetime?
Benefit Street Partners explain why it may be an opportune time to consider private debt and explores ways to take advantage of this opportunity.
-
White papers
With High Yield, Shorter May Be Better for Insurers’ Yields…and Capital Efficiency
With yield curves inverted in many parts of the world, investors no longer need to increase interest-rate risk to bolster yields. Instead, they can achieve the same end with shorter-duration high-yield bonds. For insurance investors that have typically shied away from high yield, we think this landscape—and the regulatory treatment—present a compelling opportunity.
-
White papers
Potential Opportunities in the US Banking Sector
Despite the failure of a handful of banks in the US and one in Europe, our view is that 2023 will not present a financial crisis near the magnitude of the Global Financial Crisis (GFC) in 2008. The three failed US banks, Silvergate, Silicon Valley and Signature, had unique business models that proved to be meaningful weaknesses. They raised concerns about firms with close financial ties to small banks, particularly speculative technology and related stocks, such as cryptocurrencies, that unwound when they were caught in a bubble.
-
White papers
A rocky net zero pathway calls for a new approach to portfolios
There’s a growing global consensus on the urgent need to combat climate change. But governments’ uncoordinated reactions to energy price spikes in the past year showed that a successful and orderly transition to a greener economy is far from guaranteed.
-
White papers
Turning, Not Re-Turning
It makes sense to prepare for the turning point in this cycle—but not by returning to the winners from the last cycle.
-
White papers
Crunch Time
In this monthly series, we take a quick, comprehensive look at current macroeconomic themes that matter to clients.
-
White papers
Finding the value in high-carbon sectors
The transition to net-zero greenhouse gas emissions will require radical changes to the global economy. Investors must position their portfolios to support this transition and to benefit from it.
-
White papers
Redefining Offense and Defense in Equities: The Evolution of Technology and Healthcare
Investors tend to have deeply engrained beliefs about what performs best in various market conditions—often for good reason. But sometimes, common knowledge becomes obsolete. Technology and healthcare are good examples of sectors that can play different equity-allocation roles than you might expect.
-
White papers
Tapping the Evolution in Alternative Return Streams
Institutional investors’ thinking about risk allocation has been dominated for some time by traditional beta sources, mainly long exposure to equities and bonds. The market regime provided little reason for radical change. After all, for two decades, stock and bond returns were negatively correlated, enabling 60/40 equity/bond mixes to deliver both a risk-balanced allocation framework and attractive returns.
-
White papers
Is There a New Market Context to the Case for Private Assets?
The reallocation from public to private markets has been one of the most significant portfolio rotations of the past decade. After a 2022 that saw a rapid sell-off in public equity and debt markets, some asset owners—such as many US state pension plans—find themselves overweight private assets versus targets.
-
White papers
Weathering the storm of uncertainty – how resilient is High Yield?
Holding sufficient cash, maintaining a portfolio with diverse liquidity sources, adept and nimble trading are the best ways to combat this risk.
-
White papers
Multi-asset Allocation Views: “Magical Mystery Tour”
In this Allocation Views, our Franklin Templeton Investment Solutions team believe the prospect of policy rates remaining higher for longer has been a reality check on investor sentiment and helps to reinforce the team’s preference for a moderately cautious view of stocks.
-
White papers
A non-bank lender approach to commercial real estate
Our latest private markets newsletter looks at how a non-bank lender can help institutional investors better deliver on their medium- to long-term investment targets and drive attractive relative returns.
-
White papers
What’s in Store for US Insurers in 2023?
Insurers’ risk controls and investment skills faced stiff tests in 2022, as both inflation and interest rates skyrocketed and nearly every asset class endured a sharp selloff. With traditional diversification approaches failing, investors had nowhere to hide.
-
White papers
What’s in Store for European Insurance Investors in 2023?
European insurance investors enter 2023 in healthy shape but face a less-than-stellar macro environment and regulatory change. It will take selectivity and flexibility to tap opportunities.
-
White papers
Cross Asset Investment Strategy - March 2023
European equities are favoured in a fragile earnings outlook